GOSSVSPRLD• 3 Months (Normalized)
GOSS vs PRLD (Gossamer Bio Inc. vs Prelude Therapeutics Incorporated)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.7
+6269.05%
Gossamer Bio Inc.
Normalized Baseline0.00%
PRLD Performance $4.59
+9.29%
Prelude Therapeutics Incorporated
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+6259.76%
GOSS outperforming by 6259.76%
GOSSPRLD
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS PRLD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | GOSS Price | GOSS Gain (%) | PRLD Price | PRLD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $10.70 | +6269.05% | $4.59 | +9.29% | +6259.76% |
| Sep 11, 2026 | $10.73 | +6286.90% | $4.59 | +9.29% | +6277.61% |
| Sep 10, 2026 | $11.36 | +6661.90% | $4.67 | +11.19% | +6650.71% |
| Sep 09, 2026 | $12.80 | +7519.05% | $5.09 | +21.19% | +7497.86% |
| Sep 08, 2026 | $14.40 | +8471.43% | $5.30 | +26.19% | +8445.24% |
| Sep 04, 2026 | $14.00 | +8233.33% | $5.46 | +30.00% | +8203.33% |
| Sep 03, 2026 | $14.05 | +8261.90% | $5.25 | +25.00% | +8236.90% |
| Sep 02, 2026 | $0.17 | +2.98% | $5.43 | +29.29% | -26.31% |
| Sep 01, 2026 | $0.17 | -0.60% | $5.49 | +30.71% | -31.31% |
| Aug 31, 2026 | $0.17 | +1.19% | $5.60 | +33.33% | -32.14% |
| Aug 28, 2026 | $0.17 | +1.19% | $5.47 | +30.24% | -29.05% |
| Aug 27, 2026 | $0.17 | +1.19% | $6.34 | +50.95% | -49.76% |
| Aug 26, 2026 | $0.17 | +3.57% | $6.56 | +56.19% | -52.62% |
| Aug 25, 2026 | $0.21 | +22.02% | $6.59 | +56.90% | -34.88% |
| Aug 24, 2026 | $0.18 | +4.17% | $6.47 | +54.05% | -49.88% |
Page 1 of 5